Skip to menu Skip to content Skip to footer

2020

Journal Article

Effectiveness of patient-oriented education and medication management intervention in people with decompensated cirrhosis

Hayward, Kelly L., Valery, Patricia C., Patel, Preya J., Horsfall, Leigh U., Wright, Penny L., Tallis, Caroline J., Stuart, Katherine A., David, Michael, Irvine, Katharine M., Cottrell, W. Neil, Martin, Jennifer H. and Powell, Elizabeth E. (2020). Effectiveness of patient-oriented education and medication management intervention in people with decompensated cirrhosis. Internal Medicine Journal, 50 (9), 1142-1146. doi: 10.1111/imj.14986

Effectiveness of patient-oriented education and medication management intervention in people with decompensated cirrhosis

2020

Journal Article

Nonalcoholic fatty liver disease burden: Australia, 2019–2030

Adams, Leon A., Roberts, Stuart K., Strasser, Simone I., Mahady, Suzanne E., Powell, Elizabeth, Estes, Chris, Razavi, Homie and George, Jacob (2020). Nonalcoholic fatty liver disease burden: Australia, 2019–2030. Journal of Gastroenterology and Hepatology, 35 (9), 1628-1635. doi: 10.1111/jgh.15009

Nonalcoholic fatty liver disease burden: Australia, 2019–2030

2020

Journal Article

ICD-10-AM codes for cirrhosis and related complications: key performance considerations for population and healthcare studies

Hayward, Kelly L., Johnson, Amy L., Mckillen, Benjamin J., Burke, Niall T., Bansal, Vikas, Horsfall, Leigh U., Hartel, Gunter, Moser, Chris, Powell, Elizabeth E. and Valery, Patricia C. (2020). ICD-10-AM codes for cirrhosis and related complications: key performance considerations for population and healthcare studies. BMJ Open Gastroenterology, 7 (1) e000485, 1-7. doi: 10.1136/bmjgast-2020-000485

ICD-10-AM codes for cirrhosis and related complications: key performance considerations for population and healthcare studies

2020

Journal Article

Longitudinal change in simple scores identifies fibrosis status in people with nonalcoholic fatty liver disease

McKillen, Benjamin J., Powell, Elizabeth E., Horsfall, Leigh U., Clouston, Andrew D., Brown, Nigel N., Elangovan, Harendran, Patel, Preya J., Valery, Patricia C., Irvine, Katharine M., Bernard, Anne and Hayward, Kelly L. (2020). Longitudinal change in simple scores identifies fibrosis status in people with nonalcoholic fatty liver disease. Journal of Clinical Gastroenterology, 54 (7), 661-662. doi: 10.1097/MCG.0000000000001372

Longitudinal change in simple scores identifies fibrosis status in people with nonalcoholic fatty liver disease

2020

Journal Article

Stereotactic radiotherapy for hepatocellular carcinoma: expanding the multidisciplinary armamentarium

Shanker, Mihir D., Liu, Howard Y., Lee, Yoo Young, Stuart, Katherine A., Powell, Elizabeth E., Wigg, Alan and Pryor, David I. (2020). Stereotactic radiotherapy for hepatocellular carcinoma: expanding the multidisciplinary armamentarium. Journal of Gastroenterology and Hepatology, 36 (4) jgh.15175, 873-884. doi: 10.1111/jgh.15175

Stereotactic radiotherapy for hepatocellular carcinoma: expanding the multidisciplinary armamentarium

2020

Journal Article

Type 2 diabetes: a risk factor for hospital readmissions and mortality in Australian patients with cirrhosis

Ahn, Sang Bong, Powell, Elizabeth E., Russell, Anthony, Hartel, Gunter, Irvine, Katharine M., Moser, Chris and Valery, Patricia C. (2020). Type 2 diabetes: a risk factor for hospital readmissions and mortality in Australian patients with cirrhosis. Hepatology Communications, 4 (9) hep4.1536, 1279-1292. doi: 10.1002/hep4.1536

Type 2 diabetes: a risk factor for hospital readmissions and mortality in Australian patients with cirrhosis

2020

Journal Article

Protocol for a randomised trial testing a community fibrosis assessment service for patients with suspected non-alcoholic fatty liver disease: LOCal assessment and triage evaluation of non-alcoholic fatty liver disease (LOCATE-NAFLD)

Brain, David, O'Beirne, James, Hickman, Ingrid J., Powell, Elizabeth E., Valery, Patricia C., Kularatna, Sanjeewa, Tulleners, Ruth, Farrington, Alison, Horsfall, Leigh and Barnett, Adrian (2020). Protocol for a randomised trial testing a community fibrosis assessment service for patients with suspected non-alcoholic fatty liver disease: LOCal assessment and triage evaluation of non-alcoholic fatty liver disease (LOCATE-NAFLD). BMC Health Services Research, 20 (1) 335, 335. doi: 10.1186/s12913-020-05233-2

Protocol for a randomised trial testing a community fibrosis assessment service for patients with suspected non-alcoholic fatty liver disease: LOCal assessment and triage evaluation of non-alcoholic fatty liver disease (LOCATE-NAFLD)

2020

Journal Article

Development and evaluation of the Supportive Needs Assessment Tool for Cirrhosis (SNAC)

Valery, Patricia C, Bernardes, Christina M, Stuart, Katherine A, Hartel, Gunter F, McPhail, Steven M, Skoien, Richard, Rahman, Tony, Clark, Paul J, Horsfall, Leigh U, Hayward, Kelly L, Gupta, Rohit and Powell, Elizabeth E (2020). Development and evaluation of the Supportive Needs Assessment Tool for Cirrhosis (SNAC). Patient Preference and Adherence, 14, 599-611. doi: 10.2147/ppa.s236818

Development and evaluation of the Supportive Needs Assessment Tool for Cirrhosis (SNAC)

2020

Journal Article

Changing prevalence of aetiological factors and comorbidities among Australians hospitalised for cirrhosis: the shifting epidemiology of cirrhosis

Valery, Patricia C., McPhail, Steven, Stuart, Katherine A., Hartel, Gunter, Clark, Paul J., O'Beirne, James, Skoien, Richard, Rahman, Tony, Moser, Chris and Powell, Elizabeth E. (2020). Changing prevalence of aetiological factors and comorbidities among Australians hospitalised for cirrhosis: the shifting epidemiology of cirrhosis. Internal Medicine Journal, 51 (5) imj.14809, 691-698. doi: 10.1111/imj.14809

Changing prevalence of aetiological factors and comorbidities among Australians hospitalised for cirrhosis: the shifting epidemiology of cirrhosis

2020

Journal Article

Nonalcoholic fatty liver disease: interface between primary care and hepatology clinics

Elangovan, Harendran, Rajagopaul, Sashen, Williams, Suzanne M., McKillen, Benjamin, Britton, Laurence, McPhail, Steven M., Horsfall, Leigh U., Valery, Patricia C., Hayward, Kelly L. and Powell, Elizabeth E. (2020). Nonalcoholic fatty liver disease: interface between primary care and hepatology clinics. Hepatology Communications, 4 (4) hep4.1486, 518-526. doi: 10.1002/hep4.1486

Nonalcoholic fatty liver disease: interface between primary care and hepatology clinics

2020

Journal Article

Hospitalisation for cirrhosis in Australia: disparities in presentation and outcomes for Indigenous Australians

Valery, Patricia C., Clark, Paul J., Pratt, Gregory, Bernardes, Christina M., Hartel, Gunter, Toombs, Maree, Irvine, Katharine M. and Powell, Elizabeth E. (2020). Hospitalisation for cirrhosis in Australia: disparities in presentation and outcomes for Indigenous Australians. International Journal for Equity in Health, 19 (1) 27, 1-11. doi: 10.1186/s12939-020-1144-6

Hospitalisation for cirrhosis in Australia: disparities in presentation and outcomes for Indigenous Australians

2020

Journal Article

Unusual iron and copper studies in a patient with liver injury and normocytic anemia

Ruddell, Richard G., Lee, Andrew, Powell, Elizabeth E., Wilgen, Urs and Ungerer, Jacobus P. J. (2020). Unusual iron and copper studies in a patient with liver injury and normocytic anemia. Clinical Chemistry, 66 (2), 277-281. doi: 10.1093/clinchem/hvz001

Unusual iron and copper studies in a patient with liver injury and normocytic anemia

2019

Journal Article

Clinically significant fibrosis is associated with longitudinal increases in fibrosis-4 and nonalcoholic fatty liver disease fibrosis scores

Janubhai Patel, Preya, Chieh-Yu Cheng, Johnson, Banh, Xuan, Gracen, Lucy, Radford-Smith, Daniel, Hossain, Fabrina, Horsfall, Leigh Ula, Lee Hayward, Kelly, Williams, Suzanne, Johnson, Tracey, Brown, Nigel Neil, Saad, Nivene, Stuart, Katherine Anne, Russell, Anthony William, Valery, Patricia Casarolli, Clouston, Andrew Donald, Irvine, Katharine Margaret, Bernard, Anne and Powell, Elizabeth Ellen (2019). Clinically significant fibrosis is associated with longitudinal increases in fibrosis-4 and nonalcoholic fatty liver disease fibrosis scores. Clinical Gastroenterology and Hepatology, 18 (3), 710-718.e4. doi: 10.1016/j.cgh.2019.07.036

Clinically significant fibrosis is associated with longitudinal increases in fibrosis-4 and nonalcoholic fatty liver disease fibrosis scores

2019

Journal Article

Reply

Hayward, Kelly L., Valery, Patricia C., Cottrell, W. Neil, Irvine, Katharine M., Martin, Jennifer H. and Powell, Elizabeth E. (2019). Reply. Hepatology Communications, 3 (9), 1283-1284. doi: 10.1002/hep4.1398

Reply

2019

Journal Article

Contemporary educational interventions for general practitioners (GPs) in primary care settings in Australia: A systematic literature review

Bernardes, Christina Maresch, Ratnasekera, Isanka Umayangani, Kwon, Joo Hyun, Somasundaram, Sivagowri, Mitchell, Geoff, Shahid, Shaouli, Meiklejohn, Judith, Beirne, James O., Valery, Patricia Casarolli and Powell, Elizabeth (2019). Contemporary educational interventions for general practitioners (GPs) in primary care settings in Australia: A systematic literature review. Frontiers in Public Health, 7 (JUN) 176, 1-13. doi: 10.3389/fpubh.2019.00176

Contemporary educational interventions for general practitioners (GPs) in primary care settings in Australia: A systematic literature review

2019

Journal Article

Inhibitors of class I histone deacetylases attenuate thioacetamide-induced liver fibrosis in mice by suppressing hepatic Type 2 inflammation

Loh, Zhixuan, Fitzsimmons, Rebecca L., Reid, Robert C., Ramnath, Divya, Clouston, Andrew, Gupta, Praveer K., Irvine, Katharine M., Powell, Elizabeth E., Schroder, Kate, Stow, Jennifer L., Sweet, Matthew J., Fairlie, David P. and Iyer, Abishek (2019). Inhibitors of class I histone deacetylases attenuate thioacetamide-induced liver fibrosis in mice by suppressing hepatic Type 2 inflammation. British Journal of Pharmacology, 176 (19) bph.14768, 3775-3790. doi: 10.1111/bph.14768

Inhibitors of class I histone deacetylases attenuate thioacetamide-induced liver fibrosis in mice by suppressing hepatic Type 2 inflammation

2019

Journal Article

Hyaluronan synthase 2–mediated hyaluronan production mediates Notch1 activation and liver fibrosis

Yang, Yoon Mee, Noureddin, Mazen, Liu, Cheng, Ohashi, Koichiro, Kim, So Yeon, Ramnath, Divya, Powell, Elizabeth E., Sweet, Matthew J., Roh, Yoon Seok, Hsin, I-Fang, Deng, Nan, Liu, Zhenqiu, Liang, Jiurong, Mena, Edward, Shouhed, Daniel, Schwabe, Robert F., Jiang, Dianhua, Lu, Shelly C., Noble, Paul W. and Seki, Ekihiro (2019). Hyaluronan synthase 2–mediated hyaluronan production mediates Notch1 activation and liver fibrosis. Science Translational Medicine, 11 (496) eaat9284, eaat9284. doi: 10.1126/scitranslmed.aat9284

Hyaluronan synthase 2–mediated hyaluronan production mediates Notch1 activation and liver fibrosis

2019

Journal Article

Engaging primary care clinicians in the assessment of NAFLD

Valery, Patricia C. and Powell, Elizabeth E. (2019). Engaging primary care clinicians in the assessment of NAFLD. Nature Reviews Gastroenterology and Hepatology, 16 (8), 458-460. doi: 10.1038/s41575-019-0164-4

Engaging primary care clinicians in the assessment of NAFLD

2019

Journal Article

Increasing hospitalization rates for cirrhosis: overrepresentation of disadvantaged Australians

Powell, Elizabeth E., Skoien, Richard, Rahman, Tony, Clark, Paul J., O'Beirne, James, Hartel, Gunter, Stuart, Katherine A., McPhail, Steven M., Gupta, Rohit, Boyd, Peter and Valery, Patricia C. (2019). Increasing hospitalization rates for cirrhosis: overrepresentation of disadvantaged Australians. EClinicalMedicine, 11, 44-53. doi: 10.1016/j.eclinm.2019.05.007

Increasing hospitalization rates for cirrhosis: overrepresentation of disadvantaged Australians

2019

Journal Article

Histone Deacetylase Inhibitors Attenuate Hepatic Fibrosis through Suppression of Group 2 Innate Lymphoid Cells and Type 2 Inflammation

Iyer, Abishek, Loh, Zhixuan, Fitzsimmons, Rebecca L, Reid, Robert C, Ramnath, Divya, Clouston, Andrew, Irvine, Katharine M, Powell, Elizabeth E, Schroder, Kate, Stow, Jennifer L, Sweet, Matthew J and Fairlie, David P (2019). Histone Deacetylase Inhibitors Attenuate Hepatic Fibrosis through Suppression of Group 2 Innate Lymphoid Cells and Type 2 Inflammation. The FASEB Journal, 33 (S1), 505.19-505.19. doi: 10.1096/fasebj.2019.33.1_supplement.505.19

Histone Deacetylase Inhibitors Attenuate Hepatic Fibrosis through Suppression of Group 2 Innate Lymphoid Cells and Type 2 Inflammation